{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:02:19Z","timestamp":1740146539212,"version":"3.37.3"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA152089"],"award-info":[{"award-number":["R01CA152089"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI060354"],"award-info":[{"award-number":["P30 AI060354"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R03 AI122908"],"award-info":[{"award-number":["R03 AI122908"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI106499"],"award-info":[{"award-number":["U01 AI106499"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI064002"],"award-info":[{"award-number":["U01 AI064002"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222183","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:47:52Z","timestamp":1568915272000},"page":"e0222183","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-984X","authenticated-orcid":true,"given":"Holly","family":"Janes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Glidden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan P.","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-7206","authenticated-orcid":true,"given":"Vanessa M.","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Guanira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Casapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"issue":"27","key":"pone.0222183.ref001","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"RM Grant","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"pone.0222183.ref002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0222183.ref003","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"MC Thigpen","year":"2012","journal-title":"N Engl J Med"},{"volume-title":"On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay trial","year":"2015","author":"J Molina","key":"pone.0222183.ref004"},{"issue":"10013","key":"pone.0222183.ref005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"S McCormack","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"pone.0222183.ref006","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"L Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0222183.ref007","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"JM Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"issue":"9835","key":"pone.0222183.ref008","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/S0140-6736(11)61852-7","article-title":"Pre-exposure prophylaxis for HIV prevention: how to predict success","volume":"379","author":"AD Kashuba","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"pone.0222183.ref009","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","article-title":"Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention","volume":"26","author":"A van der Straten","year":"2012","journal-title":"AIDS"},{"issue":"9","key":"pone.0222183.ref010","doi-asserted-by":"crossref","first-page":"e1001511","DOI":"10.1371\/journal.pmed.1001511","article-title":"Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa","volume":"10","author":"JE Haberer","year":"2013","journal-title":"PLoS Med"},{"key":"pone.0222183.ref011","unstructured":"Burgener A, Klatt N. Uncovering the role of the vaginal microbome in undermining PrEP efficacy in women. 21st International AIDS Conference; July 18\u201322, 2016; Durban, South Africa2016."},{"key":"pone.0222183.ref012","unstructured":"Williams BL, Lipkin I. Role of vaginal microciota in genital inflammation and enhancing HIV acquisition in women. 21st International AIDS Conference; July 18\u201321, 2016; Durban, South Africa2016."},{"issue":"7","key":"pone.0222183.ref013","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/jis465","article-title":"Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel","volume":"206","author":"V Naranbhai","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0222183.ref014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0000000000000207","article-title":"Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women","volume":"11","author":"KA Thomson","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0222183.ref015","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.aai9383","article-title":"Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women","volume":"356","author":"NR Klatt","year":"2017","journal-title":"Science"},{"issue":"112","key":"pone.0222183.ref016","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"KB Patterson","year":"2011","journal-title":"Sci Transl Med"},{"volume-title":"Concentrations of TFV and TFVdp in Female Mucosal Tissues After a Single Dose of TAF","year":"2016","author":"KL Garrett","key":"pone.0222183.ref017"},{"issue":"8","key":"pone.0222183.ref018","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/aid.2018.0031","article-title":"Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa","volume":"34","author":"H Janes","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0222183.ref019","unstructured":"endinghiv.org.au. Truvada Licensed for PrEP: ACON; 2016 [updated May 10]. Available from: http:\/\/endinghiv.org.au\/nsw\/truvada-licensed-for-prep\/."},{"key":"pone.0222183.ref020","first-page":"1","article-title":"Estimating treatment effects for individual patients based on the results of randomised clinical trials","volume":"343","author":"JAN Dorresteijn","year":"2011","journal-title":"British Medical Journal"},{"key":"pone.0222183.ref021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa1301851","article-title":"Targeting of low-dose CT screening according to the risk of lung-cancer death","volume":"369","author":"SA Kovalchik","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"pone.0222183.ref022","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/1471-2407-10-635","article-title":"A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France","volume":"10","author":"A Benchikh","year":"2010","journal-title":"BMC Cancer"},{"issue":"8","key":"pone.0222183.ref023","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1200\/JCO.2014.59.0026","article-title":"Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy","volume":"33","author":"RB Den","year":"2015","journal-title":"J Clin Oncol"},{"issue":"16","key":"pone.0222183.ref024","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.115.018383","article-title":"Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease","volume":"133","author":"G Thanassoulis","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"pone.0222183.ref025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004316","article-title":"Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease","volume":"6","author":"MJ Pletcher","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"pone.0222183.ref026","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0001-2998(78)80018-X","article-title":"Clinical Application of Decision-Analysis\u2014Detailed Illustration","volume":"8","author":"SG Pauker","year":"1978","journal-title":"Semin Nucl Med"},{"issue":"6","key":"pone.0222183.ref027","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: A novel method for evaluating prediction models","volume":"26","author":"AJ Vickers","year":"2006","journal-title":"Med Decis Making"},{"issue":"2","key":"pone.0222183.ref028","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0272989X13493147","article-title":"A framework for evaluating markers used to select patient treatment","volume":"34","author":"H Janes","year":"2014","journal-title":"Med Decis Making"},{"key":"pone.0222183.ref029","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-8-14","article-title":"Method for evaluating prediction models that apply the results of randomized trials to individual patients","volume":"8","author":"AJ Vickers","year":"2007","journal-title":"Trials"},{"issue":"5","key":"pone.0222183.ref030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM197507312930505","article-title":"Therapeutic Decision-Making\u2014Cost-Benefit Analysis","volume":"293","author":"SG Pauker","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"pone.0222183.ref031","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781139506779","volume-title":"Decision making in health and medicine: integrating evidence and values","author":"MM Hunink","year":"2014"},{"issue":"21","key":"pone.0222183.ref032","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","article-title":"Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use","volume":"34","author":"KF Kerr","year":"2016","journal-title":"J Clin Oncol"},{"key":"pone.0222183.ref033","unstructured":"US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States: A Clinical Practice Guideline. 2014."},{"key":"pone.0222183.ref034","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations 2014 [updated July]. Available from: http:\/\/www.who.int\/hiv\/pub\/guidelines\/keypopulations\/en\/."},{"issue":"1","key":"pone.0222183.ref035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cncr.27692","article-title":"Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial","volume":"119","author":"AJ Vickers","year":"2013","journal-title":"Cancer"},{"key":"pone.0222183.ref036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6215-7-30","article-title":"Selecting patients for randomized trials: a systematic approach based on risk group","volume":"7","author":"AJ Vickers","year":"2006","journal-title":"Trials"},{"issue":"6","key":"pone.0222183.ref037","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/COH.0b013e3283582c8b","article-title":"Cost-effectiveness of pre-exposure prophylaxis for HIV: a review","volume":"7","author":"BR Schackman","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"pone.0222183.ref038","doi-asserted-by":"crossref","first-page":"e1001401","DOI":"10.1371\/journal.pmed.1001401","article-title":"The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies","volume":"10","author":"GB Gomez","year":"2013","journal-title":"PLoS Med"},{"issue":"1","key":"pone.0222183.ref039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAI.0000000000000555","article-title":"Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role","volume":"69","author":"NB Carnegie","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"pone.0222183.ref040","doi-asserted-by":"crossref","first-page":"e108742","DOI":"10.1371\/journal.pone.0108742","article-title":"Clinical effectiveness and cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men: risk calculators for real-world decision-making","volume":"9","author":"A Chen","year":"2014","journal-title":"PLoS One"},{"key":"pone.0222183.ref041","article-title":"Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York City","author":"J Kessler","year":"2014","journal-title":"AIDS"},{"issue":"12","key":"pone.0222183.ref042","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1473-3099(16)30311-5","article-title":"Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study","volume":"16","author":"BE Nichols","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"pone.0222183.ref043","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"RM Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"pone.0222183.ref044","unstructured":"Gibson S, Grant R, Hall C, Sachs M, Gagliano J, Freeborn K, et al. San Francisco AIDS Foundation Launches PrEP Health Program in Community-Based Sexual Health Center. National HIV Prevention Conference. Vancouver, Canada: US CDC; 2015. p. 229\u201330."},{"issue":"1","key":"pone.0222183.ref045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services","volume":"176","author":"AY Liu","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"9","key":"pone.0222183.ref046","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/cid\/ciw022","article-title":"Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension","volume":"62","author":"DV Glidden","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pone.0222183.ref047","unstructured":"Cohen S, Vittinghoff E, Anderson P, Doblecki-Lewis S, Bacon O, Chege W, editors. Implementation of PrEP in STD and community health clinics in the US: high uptake and drug concentrations among MSM in the demo project. Available from http:\/\/www.iapac.org\/AdherenceConference\/presentations\/ADH9OA377.pdf. 9th International Conference on HIV Treatment and Prevention; 2014; Miami, Florida."},{"key":"pone.0222183.ref048","unstructured":"Cohen S, Vittinghoff E, Anderson P, Doblecki-Lewis S, Bacon O, Chege W, editors. Implementation of PrEP in STD clinics: high uptake and drug detection among MSM in the demonstration project. http:\/\/www.croiconference.org\/sessions\/implementation-prep-std-clinics-high-uptake-and-drug-detectionamong-msm-demo-project. 21st Conference on Retroviruses and Opportunistic Infections; 2014; Boston, MA."},{"issue":"1","key":"pone.0222183.ref049","doi-asserted-by":"crossref","first-page":"21472","DOI":"10.7448\/IAS.20.1.21472","article-title":"High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project","volume":"20","author":"B Hoagland","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pone.0222183.ref050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM","volume":"74","author":"SG Hosek","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"151","key":"pone.0222183.ref051","doi-asserted-by":"crossref","first-page":"151ra25","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men","volume":"4","author":"PL Anderson","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"pone.0222183.ref052","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1198\/1061860032238","volume":"12","author":"I Ruczinski","year":"2003","journal-title":"Logic Regression. Journal of Computational and Graphical Statistics"},{"issue":"2","key":"pone.0222183.ref053","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/gepi.20042","article-title":"Identifying interacting SNPs using Monte Carlo logic regression","volume":"28","author":"C Kooperberg","year":"2005","journal-title":"Genet Epidemiol"},{"key":"pone.0222183.ref054","first-page":"945","volume":"14","author":"W Nelson","year":"1972","journal-title":"Theory and applications of hazard plotting for censored failure data"},{"issue":"22","key":"pone.0222183.ref055","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jama.1995.03530220066035","article-title":"Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group","volume":"274","author":"GH Guyatt","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"pone.0222183.ref056","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0895-4356(01)00347-X","article-title":"When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment","volume":"54","author":"JC Sinclair","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"23","key":"pone.0222183.ref057","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1002\/cncr.24615","article-title":"Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach","volume":"115","author":"AJ Vickers","year":"2009","journal-title":"Cancer"},{"key":"pone.0222183.ref058","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015 [updated [updated September]; cited 2015]. Available from: http:\/\/www.who.int\/hiv\/pub\/guidelines\/earlyrelease-arv\/en\/."},{"issue":"5","key":"pone.0222183.ref059","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"NM Flynn","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0222183.ref060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.qai.0000143600.41363.78","article-title":"HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial","volume":"39","author":"BN Bartholow","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9428","key":"pone.0222183.ref061","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(04)16588-4","article-title":"Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study","volume":"364","author":"B Koblin","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"pone.0222183.ref062","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.0006-341X.2004.00242.x","article-title":"Evaluating markers for selecting a patient's treatment","volume":"60","author":"X Song","year":"2004","journal-title":"Biometrics"},{"issue":"4","key":"pone.0222183.ref063","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-154-4-201102150-00006","article-title":"Measuring the performance of markers for guiding treatment decisions","volume":"154","author":"H Janes","year":"2011","journal-title":"Ann Intern Med"},{"key":"pone.0222183.ref064","first-page":"149","article-title":"Variable Selection for Optimal Decision Making. Artificial Intelligence in Medicine","author":"L Gunter","journal-title":"Lecture Notes in Computer Science"},{"issue":"1","key":"pone.0222183.ref065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/ijb-2012-0052","article-title":"An approach to evaluating and comparing biomarkers for patient treatment selection","volume":"10","author":"H Janes","year":"2014","journal-title":"Int J Biostat"},{"issue":"282","key":"pone.0222183.ref066","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"issue":"6","key":"pone.0222183.ref067","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1473-3099(14)70025-8","article-title":"HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial","volume":"14","author":"SP Buchbinder","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"pone.0222183.ref068","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/aje\/kwv202","article-title":"Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention","volume":"182","author":"PM Murnane","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"5","key":"pone.0222183.ref069","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QAI.0000000000001160","article-title":"Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence","volume":"73","author":"B Hanscom","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"pone.0222183.ref070","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"VA Fonner","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"pone.0222183.ref071","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV pre-exposure prophylaxis (PrEP) demonstration project and safety study for young MSM","volume":"74","author":"S Hosek","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"pone.0222183.ref072","doi-asserted-by":"crossref","first-page":"e70413","DOI":"10.1371\/journal.pone.0070413","article-title":"Correlates of HIV acquisition in a cohort of black men who have sex with men in the United States: HIV Prevention Trials Network (HPTN) 061","volume":"8","author":"BA Koblin","year":"2013","journal-title":"PLoS ONE"},{"key":"pone.0222183.ref073","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-68636-3","volume-title":"Design and Analysis of Vaccine","author":"ME Halloran","year":"2010"},{"issue":"1","key":"pone.0222183.ref074","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1037\/0278-6133.26.1.60","article-title":"Effects of question format and collection mode on the accuracy of retrospective surveys of health risk behavior: a comparison with daily sexual activity diaries","volume":"26","author":"TL McAuliffe","year":"2007","journal-title":"Health Psychol"},{"issue":"2","key":"pone.0222183.ref075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1207\/S15324796ABM2602_02","article-title":"Methodological challenges in research on sexual risk behavior: I. Item content, scaling, and data analytical options","volume":"26","author":"KE Schroder","year":"2003","journal-title":"Ann Behav Med"},{"issue":"1","key":"pone.0222183.ref076","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5455\/msm.2016.28.46-50","article-title":"Instruments of High Risk Sexual Behavior Assessment: A Systematic Review","volume":"28","author":"M Mirzaei","year":"2016","journal-title":"Mater Sociomed"},{"issue":"2","key":"pone.0222183.ref077","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/sim.7296","article-title":"Constrained binary classification using ensemble learning: an application to cost-efficient targeted PrEP strategies","volume":"37","author":"W Zheng","year":"2018","journal-title":"Stat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:37:08Z","timestamp":1589038628000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222183"}},"subtitle":[],"editor":[{"given":"Ethan","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222183","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,9,19]]}}}